Small Molecules for Treatment of Huntington's Disease and Related Disorders
OverviewTrinucleotide repeats expansion disorders (TREDs) are a set of diseases in which repetitions of short DNA segments (three nucleotides) occur and accumulate in the genome. This is the c...
Read moreYeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education.
1
PointAR
The PointAR System allows PEOPLE in the field to receive critical guidance from expert support staff with existing technologies such as AR, smartphones, tablets, etc.
news & events
All News-
Sunday, March 26, 2023Prof. Michal Schwartz, shares her journey of finding a way to cure Alzheimer's
-
Sunday, March 26, 2023Congratulations to Yeda’s spinoff company, Curesponse!
-
Thursday, March 9, 2023Registration for Neurotechnology 2023 is now open!
-
Monday, March 6, 2023Congratulations to Prof. Nir London
-
Monday, March 6, 2023Exciting things are happening in the world of Cardiology
-
Sunday, February 26, 2023Yeda announces partnership with eureKARE, to establish EonBio!
-
Wednesday, February 15, 2023This Valentine’s Day, let’s take a moment to talk about Heart health. ❤️ ️
-
Tuesday, February 14, 2023Stimulating Production and Extraction of Metabolites in Plants
-
Tuesday, February 7, 2023Revolutionary discovery places Xinteza at the forefront of cannabinoid sourcing
-
Sunday, February 5, 2023Meet Prof. Adi Kimchi, a principal investigator at the Molecular Genetics department.
-
Monday, January 30, 2023The race to build the next generation of computers is on!
-
Monday, January 30, 2023Protein comes in many shapes and forms, from meat and dairy to beans and bugs!
-
Tuesday, January 24, 2023Decentralized low-cost emissions-free ammonia via electro catalytic reaction of water and air.
-
Thursday, January 19, 2023IndieBio San Francisco - Batch 13 Demo Day is taking place tomorrow (January 19).
-
Thursday, January 12, 2023Yeda's Newsletter - Jan 2023
-
Wednesday, January 11, 2023Something exciting is happening in the world of Quantum Computing!
-
Sunday, December 25, 2022Congratulations to the team at Curesponse
-
Thursday, December 22, 2022Kadimastem - US $1 Million BIRD Foundation Grant
-
Wednesday, December 21, 2022BUZZING with innovation
-
Wednesday, December 21, 2022Happy Hanukah Prof. Boris Rybtchinski and his team
-
Sunday, December 11, 2022Super-Resolution Using Unsupervised Deep Internal Network (No. T4-1850)
-
Wednesday, December 7, 2022Good news for cardiac sonographers
-
Wednesday, November 30, 2022Yeda’s Newly Established Carbon To Value Spinoff - Carbonade
-
Thursday, November 24, 2022Joint program to make next-generation joint lubrication technology
-
Sunday, November 20, 2022UltraSight
-
Tuesday, November 15, 2022לנצח את החיידק
-
Tuesday, November 15, 2022Yeda spinoff company in C&EN's 10 Start-Ups to Watch
-
Tuesday, November 15, 2022Metabolic Insights has signed an agreement with the RATION Consortium
-
Sunday, November 6, 2022Yeda is judging at the AgriVest Conference
-
Sunday, November 6, 2022ClimateCrop @ COP27
-
Wednesday, November 2, 2022Sequentify
-
Thursday, October 27, 2022Facts and Figures 2021
-
Monday, October 24, 2022Novel Combination Therapy For Improved Management of Depression
-
Wednesday, October 19, 2022BIO-Europe 2022
-
Thursday, September 22, 2022Israel’s ProFuse Technology raises $2.5M
-
Monday, September 19, 2022Cannabinoid biosynthesis production systems
-
Sunday, September 18, 2022Putting Liquid Biopsies on Solid Ground: Cancer Diagnosis from a Milliliter of Blood
-
Sunday, September 11, 2022A Sustainable Process for Phenol Production
-
Sunday, September 11, 2022We are excited to announce that the eBeam4Therapy kick-off has already started!
-
Monday, September 5, 2022The Weizmann Institute of Science is ranked number 8 on the Leiden global ranking
-
Monday, August 29, 2022Multimodel Transcranial Optical Vascular Assessment
-
Monday, August 29, 2022Congratulations UltraSight,
-
Tuesday, August 23, 2022New findings how to treat inflammatory bowel disease
-
Tuesday, August 16, 2022A new source of cannabinoid biosynthesis
-
Tuesday, August 16, 2022המייסדים של לייטסולבר רוצים לפתח את המחשב המהיר בעולם (ובינתיים הולך להם לא רע)
-
Wednesday, August 10, 2022The scientist who created a mouse - Podcast
-
Wednesday, August 10, 2022A seed investment has been made in ClimateCrop - photosynthesis enhancement Ltd, a spinoff from Yeda
-
Monday, August 8, 2022Yeda spinoff company leveraging breakthrough stem cell technologies
-
Monday, August 8, 2022Climate Crop is a Yeda Spinoff
-
Monday, August 1, 2022Scan, save and share the most precious photos and memories
-
Monday, July 25, 2022Next-generation technologies will be based on smell
-
Monday, July 25, 2022Today Yeda's Team had the pleasure to visit the INCPM center
-
Thursday, July 21, 2022A brilliant solution has been developed by Weizmann Institute of Science professor, Yonina Eldar
-
Wednesday, July 20, 2022Phytolon, is emerging as an important player in the food dye market
-
Tuesday, July 5, 2022Yeda's Newsletter - June 2022
-
Tuesday, May 24, 2022Yeda Subsidiary Start-Ups Make Headlines Worldwide
-
Tuesday, May 3, 2022Yeda @ Bio 2022
-
Tuesday, April 12, 2022Lysogene Enters into an Exclusive Worldwide License Agreement with Yeda
-
Tuesday, February 8, 2022Without Fasting and Anesthesia: The Non-Invasive Test that May Replace Colonoscopy (Hebrew)
-
Tuesday, February 8, 2022Viruses in Service of Man - Fight Against Bacterial Diseases in Agriculture (Hebrew)
-
Tuesday, January 25, 2022Monte Rosa Therapeutics and Yeda Announce Collaboration
-
Sunday, January 23, 2022Yeda's Newsletter - Jan 2022
-
Wednesday, August 4, 2021Impact NRS create Plantea Bioscience
-
Monday, May 10, 2021Yeda - Where Science Means Business
-
Tuesday, April 27, 2021Treating Chronic Diseases and Cancer
-
Tuesday, April 20, 2021Hunger Switch in the Brain
-
Wednesday, March 24, 2021Inspired by Cartilage - Liposphere
-
Monday, March 8, 2021An interview with Yeda's CEO
-
Sunday, January 10, 2021Planting Seeds for Better Nutrition and Sustainability
-
Sunday, January 3, 2021Top Influencers of Maariv - 25th Place
-
Tuesday, October 6, 2020A groundbreaking antibody treatment for Alzheimer’s disease
-
Wednesday, September 16, 2020Israeli natural food coloring co Phytolon raises $4.1m
-
Tuesday, September 8, 2020Greener Farming - EcoPhage
-
Tuesday, September 1, 2020Potential Heart-Repair Protein Advances to a New Stage
-
Tuesday, August 18, 2020A New Method for Seeing into Cells
-
Friday, August 14, 2020Weizmann Institute’s new technology may help treat cancer
-
Thursday, August 13, 2020COVID-19 Supports Agrifood Startups
-
Tuesday, July 14, 2020Personalized Nutrition - DayTwo
-
Monday, July 6, 2020Lysogene, Weizmann Institute Team Up on Gene Therapy for Neuronopathic Gaucher
-
Wednesday, June 10, 2020Weizmann - Top 25 Universities
-
Thursday, April 23, 2020Breaking New Ground in Head Injury Treatment
-
Wednesday, April 22, 2020COVID-19 Research Cooperation
-
Sunday, April 19, 2020Weizmann Race for COVID 19 Drug
-
Sunday, April 5, 2020Stem Cells Provide COVID-19 Relief
-
Thursday, April 2, 2020Article of the Month – Top TTO Challenges
-
Tuesday, March 31, 2020BiomX Positive Phase 1 Study for Acne
-
Monday, March 30, 2020A Nose for Coronavirus Detection
-
Wednesday, March 18, 2020Today's Research is Tomorrow's Viral Threat Defense
-
Tuesday, January 28, 2020Frontier Tech - Israel's First Deep Tech
-
Thursday, January 9, 2020Yeda and Deerfield Create Orchard Innovations - $130 Million
-
Monday, January 6, 2020Yeda and Deerfield Create Orchard Innovations (Hebrew PR)
-
Thursday, March 21, 2019Korea's Bio-Leaders To Invest $10 Million in Weizmann Institute Anti-Cancer Therapy
-
Sunday, July 8, 2018Weizmann Institute of Science is Ninth in the World in Research Quality
-
Friday, April 27, 2018One Patent, Three Drugs // Eli Lilly and Company
-
Monday, January 1, 2018Gil Granot-Mayer Will Replace Amir Naiberg as CEO of Yeda
-
Tuesday, December 26, 201713 of the biggest health breakthroughs in Israel in 2017
-
Thursday, May 5, 2016Technology transfer trends at the Weizmann Institute of Science
-
Sunday, March 13, 2016
New Options for Prostate Cancer Patients - EAU16 Plenary Session 2
-
Tuesday, February 16, 2016Karl-Ludwig Kley Receives Weizmann Award in the Sciences and Humanities
-
Tuesday, February 16, 2016Merck and Weizmann Institute Sign New Framework Agreement on Research Collaboration
-
Monday, January 4, 2016TOOKAD® Soluble, Approved for Prostate Cancer Therapy in Mexico
-
Wednesday, December 2, 2015How new fuel tech could drastically reduce CO2 and generate profitable new waste stream
-
Wednesday, December 2, 2015For Israeli firm, an answer to global warming is blowing in the wind
-
Thursday, February 12, 2015ImmunArray Ltd announces the Launch of the SLE-key™ Rule Out test
-
Monday, December 1, 2014The Interferon Connection
-
Wednesday, July 25, 2012‘3i’ to Develop Microscopes of the Future Based on Weizmann Institute Inventions
-
Thursday, June 7, 2012Weizmann Institute Solar Technology to Convert Greenhouse Gas into Fuel
